GMS 6504 AdvMed PS3 Exam Questions
With Correct Answers
An |antagonist |that |has |concentration |where |addition |of |more |antagonist |will |have |no |
additional |measurable |effect |is |called |___. |- |CORRECT |ANSWER✔✔-Saturable
A |more |potent |antagonist |will |have |a |___ |pA2. |- |CORRECT |ANSWER✔✔-lower
A |Schild |analysis |reveals |a |graph |that |resembles |a |y |= |x^2 |graph. |This |antagonist |is |most |likely |
___. |- |CORRECT |ANSWER✔✔-Noncompetitive
A |reversible |inverse |agonist |applied |to |a |system |that |does |not |contain |constitutive |actively |will
|appear |to |behave |most |like |a(n) |___ |antagonist. |- |CORRECT |ANSWER✔✔-Competitive
True |or |false? |It |is |possible |for |a |competitive |antagonist |and |an |allosteric |modulator |to |have |
synergistic |effects |in |blocking |agonist |binding. |(This |probably |wasn't |discussed |in |the |lecture. |
You |have |to |think |about |it.) |- |CORRECT |ANSWER✔✔-True
An |allosteric |modulator |with |alpha |> |1, |beta |= |1 |is |best |classified |as |a |___. |- |CORRECT |
ANSWER✔✔-PAM
An |allosteric |modulator |that |increases |affinity |while |decreasing |efficacy |is |best |classified |as |a |
___. |- |CORRECT |ANSWER✔✔-PAM-antagonist
True |or |false? |An |allosteric |modulator |may |be |a |NAM |when |applied |with |one |agonist |and |a |
PAM |when |applied |with |a |different |agonist. |(This |probably |wasn't |discussed |in |the |lecture. |You
|have |to |think |about |it.) |- |CORRECT |ANSWER✔✔-True
With Correct Answers
An |antagonist |that |has |concentration |where |addition |of |more |antagonist |will |have |no |
additional |measurable |effect |is |called |___. |- |CORRECT |ANSWER✔✔-Saturable
A |more |potent |antagonist |will |have |a |___ |pA2. |- |CORRECT |ANSWER✔✔-lower
A |Schild |analysis |reveals |a |graph |that |resembles |a |y |= |x^2 |graph. |This |antagonist |is |most |likely |
___. |- |CORRECT |ANSWER✔✔-Noncompetitive
A |reversible |inverse |agonist |applied |to |a |system |that |does |not |contain |constitutive |actively |will
|appear |to |behave |most |like |a(n) |___ |antagonist. |- |CORRECT |ANSWER✔✔-Competitive
True |or |false? |It |is |possible |for |a |competitive |antagonist |and |an |allosteric |modulator |to |have |
synergistic |effects |in |blocking |agonist |binding. |(This |probably |wasn't |discussed |in |the |lecture. |
You |have |to |think |about |it.) |- |CORRECT |ANSWER✔✔-True
An |allosteric |modulator |with |alpha |> |1, |beta |= |1 |is |best |classified |as |a |___. |- |CORRECT |
ANSWER✔✔-PAM
An |allosteric |modulator |that |increases |affinity |while |decreasing |efficacy |is |best |classified |as |a |
___. |- |CORRECT |ANSWER✔✔-PAM-antagonist
True |or |false? |An |allosteric |modulator |may |be |a |NAM |when |applied |with |one |agonist |and |a |
PAM |when |applied |with |a |different |agonist. |(This |probably |wasn't |discussed |in |the |lecture. |You
|have |to |think |about |it.) |- |CORRECT |ANSWER✔✔-True
